New Delhi — HLL Lifecare Limited, a Mini-Ratna public-sector enterprise under the Ministry of Health and Family Welfare, has paid a dividend of ₹69.53 crore to the Government of India for the financial year 2024–25.
According to figures shared by the company, revenue from operations during the year stood at around ₹4,500 crore, showing an increase of about 20 per cent over the previous year.
The company’s net worth was ₹1,100 crore as on 31 March 2025. On a consolidated basis, which includes subsidiaries HITES, GAPL and Lifespring Hospitals, total revenue reached ₹4,900 crore, representing a rise of 19 per cent compared with the preceding fiscal.
Officials in the Health Ministry said the results indicate stable performance across HLL’s manufacturing and service portfolios. The enterprise continues to supply medical devices, diagnostic products and other healthcare goods to government programmes and public-sector clients.
HLL Lifecare was set up in 1966 and functions under the Ministry of Health and Family Welfare. It has gradually diversified from its original role in population-control products into a broader healthcare manufacturing and services organisation. Its operations now cover pharmaceuticals, hospital project services, procurement and public-health supply chains.
HLL Lifecare delivers stable performance
The company also manages the Amrit Pharmacy network, established to provide essential medicines and surgical consumables at regulated prices through outlets attached to major hospitals and medical institutions.
The scheme is intended to reduce out-of-pocket expenditure for patients and ensure the availability of standard medicines.
During 2024–25, HLL’s manufacturing divisions reported steady demand for healthcare consumables and devices, while its service subsidiaries handled procurement, consultancy and hospital-management projects.
Officials said the dividend payment reflects the company’s financial position and the returns generated from its business operations. HLL Lifecare remains among the key public-sector organisations engaged in the production and supply of medical and healthcare products for government programmes.
The dividends payment for the financial year 2024–25 is among the highest dividends paid by HLL to date.
